Jensen, B. T., Dielenseger, P., Drudge-Coates, L., Flynn, K., Hieronymi, S., van Muilekom, E., Pieters, R. & Bjerregaard Voss, L. (2011).
Taking the lead - best practice recommendations for intravenenous bisphosphonate use in urological cancers.
European Journal of Oncology Nursing.
Jespersen, C. G., Noergaard, M., Johansen, T. E. B., Soegaard, M. & Borre, M. (2011).
The influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort study.
B M C Cancer,
11(1), 519.
https://doi.org/10.1186/1471-2407-11-519
Jensen, M. S., Olsen, L. H., Thulstrup, A. M., Olsen, J., Bonde, J. P.
& Henriksen, T. B. (2010).
Age at cryptorchidism diagnosis and orchiopexy in Denmark: A population-based study of 508,964 boys born from 1995 to 2009: European Academy of Paediatric Societies (EAPS), Copenhagen, Denmark.
Jensen, M. S., Olsen, L. H., Thulstrup, A. M., Olsen, J., Bonde, J. P.
& Henriksen, T. B. (2010).
Age at cryptorchidism diagnosis and orchiopexy in Denmark: A population-based study of 508,964 boys born from 1995 to 2009: American Academy of Pediatrics (AAP), San Francisco, USA.
Søndergaard, J., Olsen, K. Ø., Muren, L., Elstrøm, U. V., Grau, C. & Høyer, M. (2010).
A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall.
Acta Oncologica,
49(7), 1109-1115.
https://doi.org/10.3109/02841861003789491
Ostenfeld, M. S., Bramsen, J. B., Lamy, P., Villadsen, S. B., Fristrup, N., Dalsgaard Sørensen, K., Ulhøi, B. P., Borre, M., Kjems, J., Andersen, L. D. & Ørntoft, T. F. (2010).
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.
Oncogene,
29(7), 1073.
https://doi.org/10.1038/onc.2009.395
Lund, L., Jacobsen, J., Clark, P.
, Borre, M., Nørgaard, M. & Northern Danish Cancer Quality Assessment Group (2010).
Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study.
Urology,
75(2), 393-8.
https://doi.org/10.1016/j.urology.2009.07.1320
Niemann, A. K., Udesen, J.
, Thrysøe, S. A., Nygaard, J. V., Fründ, E.-T. W., Petersen, S. E. & Hasenkam, J. M. (2010).
Can sites prone to flow induced vascular complications in a-v fistulas be assessed using computational fluid dynamics? Journal of Biomechanics,
43(10), 2002-9.
https://doi.org/10.1016/j.jbiomech.2010.02.037
Ravlo, K., Secher, N. G., Søndergaard, P., Keller, A. K., Petersen, M. S., Kofoed-Nielsen, P. B., Møller, B. K., Jørgensen, T. M., Tønnesen, E. K. & Jespersen, B. (2010).
Effect of remote ischemic preconditioning on dendritic cells in blood after renal transplantation - flow cytometry in a porcine model.. Poster session presented at XXIII International Congress of the Transplantation Society, Vancouver.
Ravlo, K., Secher, N. G., Søndergaard, P., Keller, A. K., Petersen, M. S., Kofoed-Nielsen, P. B., Møller, B. K., Jørgensen, T. M., Tønnesen, E. K. & Jespersen, B. (2010).
Effect of remote ischemic preconditioning on dendritic cells in blood after renal transplantation - flow cytometry in a porcine model.. Poster session presented at Scandinavian Transplant Congress, Helsinki, Finland.
James, N. D., Caty, A., Payne, H.
, Borre, M., Zonnenberg, B. A., Beuzeboc, P., McIntosh, S., Morris, T., Phung, D. & Dawson, N. A. (2010).
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial.
B J U International (Print),
106(7), 966-73.
https://doi.org/10.1111/j.1464-410X.2010.09638.xBrems-Eskildsen, A. S., Zieger, K. E. A., Toldbod, H., Holcomb, C., Higuchi, R.
, Mansilla, F., Munksgaard, P. P., Borre, M., Ørntoft, T. F. & Andersen, L. D. (2010).
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
B M C Cancer,
10(1), 646.
https://doi.org/10.1186/1471-2407-10-646
Vestergaard, E. M., Nexø, E., Tørring, N., Borre, M., Ørntoft, T. F. & Sørensen, K. D. (2010).
Promoter hypomethylation and upregulation of trefoil factors in prostate cancer.
International Journal of Cancer,
127(8), 1857-65.
https://doi.org/10.1002/ijc.25209
Jørgensen, B., Karstoft, K.
, Jørgensen, T. M., Rittig, S., Frøkiær, J. & Pedersen, M. (2010).
Structural and functional MRI in children with renal disease: first experience.
Zeitschrift fuer Medizinische Physik,
20(2), 115-21.
https://doi.org/10.1016/j.zemedi.2010.01.004
Nielsen, T. K., Mølgaard, H., Ringsted, C.
, Eika, B. & Ringsted, C. (2010).
The development of a new cardiac auscultation test: How do screening and diagnostic skills differ? Medical Teacher,
32(1), 56-61.
https://doi.org/10.1080/01421590802572767
Jørgensen, T. M., Rawashdeh, Y. F. H., Mouriquand, P., Koyle, M., Ost, M. & Docimo, S. (2010).
Ureteropelvic Junction Obstruction: Contemporary Approaches to Several Case Scenarios.
Dialogues in Pediatric Urology,
31(3).
Zieger, K., Marcussen, N., Borre, M., Ørntoft, T. F. & Andersen, L. D. (2009).
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.
International Journal of Cancer,
125(9), 2095-103.
https://doi.org/10.1002/ijc.24619
Zieger, K., Wiuf, C. H., Jensen, K. M.-E., Ørntoft, T. F. & Andersen, L. D. (2009).
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer. B M C Cancer,
9, 149.
Cytron, S., Greene, D., Witzsch, U., Nylund, P.
& Johansen, T. E. B. (2009).
Cryoablation of the prostate: technical recommendations.
Prostate Cancer and Prostatic Diseases,
12(4), 339-46.
https://doi.org/10.1038/pcan.2009.26Mortensen, M. M., Nygaard, J. V., Hønge, J. L., Lee, D.
& Hasenkam, J. M. (2009).
Development and evaluation of a tissue-engineered trilaminar scaffold for heart valve replacement, Martin Mortensen. Poster session presented at iNANO 7
th annual meeting, Aarhus, Denmark.
Ahlgren, G., Flodgren, P., Tammela, T., Kellokumpu-Lehtinen, P.-L., Sengelöv, L.
, Borre, M., Angelsen, A. & Iversen, JR. (2009).
Experiences from a randomized trial on adjuvant docetaxel after radical prostatectomy for high risk prostate cancer - the SPCG 12 study. Poster session presented at The 2nd European Multidisciplinary Meeting on Urological Cancers (EMUC), Barcelona, Spain.
Fristrup, N., Andersen, L. D., Ørntoft, T. F., Ulhøi, B. P. & Borre, M. (2009).
Expression of Maspin, Survin and Cathespin E predict progression in non-muscle invasive bladder cancer. Poster session presented at NUF, Iceland.
Jensen, J. B., Jensen, K. M.-E., Ulhøi, B. P., Ørntoft, T. F. & Andersen, L. D. (2009).
Gene expression signature for metastatic urothelial carcinoma of the urinary bladder. Poster session presented at EAU 24th Congress, Stockholm, Sweden.
Sørensen, K. D., Wild, P. J., Mortezavi, A.
, Adolf, K., Tørring, N., Heebøll, S., Ulhøi, B. P., Ottosen, P., Sulser, T., Hermanns, T., Moch, H.
, Borre, M., Ørntoft, T. F. & Dyrskjøt, L. (2009).
Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy.
Clinical Cancer Research,
15(4), 1400-1410.
https://doi.org/10.1158/1078-0432.CCR-08-2268
Andersen, L. D., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A.
, Lamy, P., Ramanathan, R., Fristrup, N., Jensen, J. L., Andersen, C. L., Zieger, K., Kauppinen, S.
, Ulhøi, B. P., Kjems, J., Borre, M. & Ørntoft, T. F. (2009).
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Research,
69(11), 4851-60.
https://doi.org/10.1158/0008-5472.CAN-08-4043
